Emily A. Gomme, Ph.D.

Director, High-throughput Clinical Immunoassays & Diagnostics
Pfizer
Westwood, New Jersey, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 91 - Establishing Proof of Concept for a Bivalent RSVpreF Subunit Vaccine for Maternal Immunization

  Thursday, October 20, 2022
  10:30 AM – 10:45 AM US ET